New podcast episode: The REFINE trial: how can we improve the way we give cancer immunotherapy?

17 Jul 2023

A new episode of Trial Talk has been released today! 

In this episode, we explore how the REFINE trial aims to improve the use of immunotherapy to treat cancer.  

Sophie Merrick, a Clinical Fellow from the MRC CTU at UCL, talks about the challenges of using immunotherapy drugs and how REFINE is testing whether giving these drugs less frequently can still treat the cancer effectively whilst improving the quality of life for patients. She also discusses OPTIC, a study looking at patients views on changing the way we give immunotherapy. 

Access the transcript.

If you enjoyed this episode, don't forget to subscribe to our SoundCloud channel for more content (click the “Follow” icon). 

The Trial Talk podcast is hosted and produced by Charlotte Hartley and Berta Terre-Torras, our Science Communications Officers. For questions or feedback on the series, message us on Twitter @MRCCTU, LinkedIn, or send us an email. 

Further information: